MACULAR ATROPHY AND PHENOTYPIC VARIABILITY IN AUTOSOMAL DOMINANT STARGARDT-LIKE MACULAR DYSTROPHY DUE TO PROM1 MUTATION

Retina. 2023 Jul 1;43(7):1165-1173. doi: 10.1097/IAE.0000000000003784.

Abstract

Purpose: To describe the phenotypic variability and rates of progression of atrophy in patients with PROM1 -associated macular dystrophy.

Methods: Patients in this retrospective, longitudinal case series from a tertiary center had clinical examination and multimodal imaging performed. Areas of retinal pigment epithelium and ellipsoid zone loss over time by optical coherence tomography were calculated by two independent graders.

Results: Fifteen patients from five kindreds with an Arg373Cys mutation in PROM1 were studied. The average age was 39 years, and 80% were women. The visual acuity was 20/40 at presentation and 20/57 at last follow-up (average 4.8 years). Three distinct macular phenotypes were observed: 1) central geographic atrophy (13%), 2) multifocal geographic atrophy (20%), and 3) bull's eye maculopathy (67%). The overall rate of atrophy progression was 0.36 mm 2 /year, but the average rate of atrophy progression varied by macular phenotype: 1.08 mm 2 /year for central geographic atrophy, 0.53 mm 2 /year for multifocal geographic atrophy, and 0.23 mm 2 /year for bull's eye maculopathy.

Conclusion: Patients with PROM1 -associated macular dystrophy demonstrate distinct phenotypes, with bull's eye maculopathy being the most common. The average rate of atrophy progression may be similar to reported rates for ABCA4 -related Stargardt disease and less than age-related macular degeneration. These results provide important measures for following treatment response in future gene and stem cell-based therapies.

MeSH terms

  • AC133 Antigen / genetics
  • ATP-Binding Cassette Transporters / genetics
  • Atrophy
  • Biological Variation, Population
  • Female
  • Fluorescein Angiography
  • Geographic Atrophy*
  • Humans
  • Macular Degeneration* / diagnosis
  • Macular Degeneration* / genetics
  • Male
  • Mutation
  • Retrospective Studies
  • Tomography, Optical Coherence

Substances

  • ABCA4 protein, human
  • ATP-Binding Cassette Transporters
  • PROM1 protein, human
  • AC133 Antigen

Supplementary concepts

  • Macular dystrophy, concentric annular